Search
SOLACI Congress
HomeESC 2015Highlights

Highlights

      View Category
      Drug-eluting stents

      OPTIDUAL: Dual Antiaggregation Not Beneficial after 12 Months.

      Extending dual antiaggregation therapy (DAT) from 12 to 48 months appears not to offer extra protection after...
      solaci -
      Learn More
      Highlights

      Meta-analysis of prolonged DAT after DES

      Extending the antiaggregation therapy over a year reduces adverse events in patients with a history of AMI,...
      solaci -
      Learn More
      Highlights

      FAME at 5 years: FFR Should Guide All Multivessel PCIs

      Though the benefit of FFR (fractional flow reserve) over angiography is statistically important only over the first...
      solaci -
      Learn More
      Acute coronary syndromes

      BACC: Protocol for Rapid Diagnosis of Myocardial Infraction

      The 1-hour algorithm using high-sensitivity troponin measurement for rapid diagnosis of AMI is safe. To carry out the...
      solaci -
      Learn More

      SOLACI is the reference organization for Latin American cardiovascular interventionism.

      Last News

      Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

      Dr. Omar Tupayachi - 0
      Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

      Is it really necessary to monitor all patients after TAVR?

      Dr. Juan Manuel Pérez - 0
      Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

      Is it really necessary to monitor all patients after TAVR?

      Dr. Juan Manuel Pérez - 0
      Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

      Institutional News

      Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

      solaci - 0
      Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

      Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

      solaci - 0
      Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

      25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

      solaci - 0
      The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

      Access

      Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy